Last reviewed · How we verify
NCT06190288: AdvantAGE
AdvantAGE: Implementation and Evaluation of an Interprofessional Tranistional Care Model for Frail Older Adults
NA trial testing Transitional care model in Transitional Care in 250 participants. Currently enrolling.
30 June 2026
Quick facts
| Lead sponsor | Thekla Brunkert |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 250 |
| Start date | 8 January 2024 |
| Primary completion | 30 June 2026 |
| Estimated completion | 30 June 2026 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Transitional care model
Conditions studied
- Transitional Care — all drugs for Transitional Care →
- Multimorbidity — all drugs for Multimorbidity →
- Geriatric Care — all drugs for Geriatric Care →
Sponsor
Thekla Brunkert
Who can join
65 and older, any sex, with Transitional Care or Multimorbidity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial at the University Department of Geriatric Medicine FELIX Platter in Basel, Switzerland, is designed to evaluate a new transitional care model aimed at helping frail older adults after they get discharged from the hospital. The AdvantAGE study aims to explore the following questions: * Does the new care model help reduce the number of patients who need to return to the hospital within 90 days? * How effective is the implementation of this care model? Participants in the trial will be followed by advanced practice nurses for up to 90 days after hospital discharge. The patients and their caregivers will receive support in coordinating care, managing medications, and learning to manage the patient's health conditions on their own. Additionally, they will have the opportunity to engage in discussions about advanced care planning.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
AdvantAGE: Implementation and Evaluation of an Interprofessional Transitional Care Model for Frail Older Adults-Protocol of an Effectiveness-Implementation Hybrid Study.
Brunkert T, Pfundstein I, Nickel CH, Lampert ML, et al · · 2025 · PMID 39865439 · DOI 10.1111/jan.16745
Verify or expand the search:
- PubMed search for NCT06190288
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transitional care model
Trials testing the same drug.
- NCT06280599 — Transitional Care Model for Patients With Stroke · NA · recruiting
- NCT05525793 — Effectiveness of the Transitional Care Model in Total Knee Arthroplasty Patients · NA · completed
- NCT03708835 — The Effect of Transitional Care Model-Based Interventions for Stroke Patients and Their Caregivers · NA · completed
Other recruiting trials for Transitional Care
Currently open trials in the same condition.
- NCT07310199 — Pharmacist-Led Transition of Care Program in the Emergency Department (Pharm TOC-ED): A Pilot Trial · NA · recruiting
- NCT06242366 — Transitional Care Program in Stroke Patients With Hemiplegia. · NA · recruiting
- NCT05806606 — Effect and Cost Effectiveness of a Dyadic Empowerment-based Heart Failure Management Program for Self-care · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06190288 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Thekla Brunkert
- Last refreshed: 2 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06190288.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing